ABG
PMN icon

Ally Bridge Group’s ProMIS Neurosciences PMN Stock Holding History

Ally Bridge Group’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.26M Buy
414,219
+164,880
+66% +$2.46M 4.25% 10
2025
Q4 		$1.7M Sell
249,339
-1
-0% -$10 1.77% 18
2025
Q3 		$2.65M Buy
249,340
+195,963
+367% +$2.71M 1.61% 19
2025
Q2 		$646K Sell
53,377
-6,011
-10% -$82K 0.54% 24
2025
Q1 		$1.03M Sell
59,388
-4,316
-7% -$91.6K 0.93% 26
2024
Q4 		$1.51M Hold
63,704
– – 1.29% 29
2024
Q3 		$1.99M Buy
63,704
+21,321
+50% +$796K 1.07% 29
2024
Q2 		$1.59M Hold
42,383
– – 0.95% 25
2024
Q1 		$2.02M Sell
42,383
-284
-0.7% -$14.1K 1.13% 21
2023
Q4 		$1.23M Buy
42,667
+21,390
+101% +$800K 0.73% 20
2023
Q3 		$1.05M Buy
+21,277
New +$1.38M 1.24% 18

Other funds holding PMN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ally Bridge Group's PMN Position: Q1 2026 in Review

Ally Bridge Group increased its ProMIS Neurosciences (PMN) stake by 66% in Q1 2026, buying an estimated $2.46M and bringing the position to 414,219 shares worth $5.26M. The position accounts for 4.25% of the portfolio, ranked #10.

Ally Bridge Group first reported a position in PMN in Q3 2023 and has held it in 11 quarters since. 25 funds tracked by Wall St. Rank hold PMN as of Q1 2026.

  • Ally Bridge Group held 414,219 shares of ProMIS Neurosciences worth $5.26M as of Q1 2026.
  • Ally Bridge Group bought 164,880 ProMIS Neurosciences shares in Q1 2026, an estimated $2.46M.
  • ProMIS Neurosciences made up 4.25% of Ally Bridge Group's portfolio in Q1 2026, its #10 holding.
  • Ally Bridge Group first reported a position in ProMIS Neurosciences in Q3 2023 and has held it in 11 quarters since.
  • 25 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2026.

Based on Ally Bridge Group's 13F filing for Q1 2026, filed 18 May 2026.